APA (7th ed.) Citation

M, H., A, G., T, F., A, R., A, V., J, S., & M, A. (2022). Design and stability of pediatric oral formulation of imatinib. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 28(2), 337. https://doi.org/10.1177/1078155221991200

Chicago Style (17th ed.) Citation

M, Hinterlang, Gendron A, Fleury T, Rieutord A, Vrana A, Schlatter J, and Annereau M. "Design and Stability of Pediatric Oral Formulation of Imatinib." Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners 28, no. 2 (2022): 337. https://doi.org/10.1177/1078155221991200.

MLA (9th ed.) Citation

M, Hinterlang, et al. "Design and Stability of Pediatric Oral Formulation of Imatinib." Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners, vol. 28, no. 2, 2022, p. 337, https://doi.org/10.1177/1078155221991200.